ABOUT THE CONGRESS

The key theme of the third edition of Next Frontiers to Cure Cancer is Science and Innovation, Patient to Patient. From May 10 to 12, 2018, specialists from distinguished international and Brazilian organizations will be together to discuss the oncology progress and innovations in 10 relevant fields of study. The congress takes place at the WTC Events Center, in the city of São Paulo.

Multidisciplinary discussions will take place concurrently in 8 rooms on skin, brain, pediatric, lung, head and neck cancer besides innovations and technologies in basic and translational research in immunotherapy, hematology/oncology and oncogenetics.

The 25th Pathology Meeting will be held in parallel to the Congress. In 2018, the Pathology Meeting will focus on Head and Neck tumors and Patients Forum with discussions about the major day to day issues, from diagnosis to rehabilitation.

MESSAGE FROM THE SCIENTIFIC COMMITEE

Prof. Dr. Ademar Lopes

 

Ademar Lopes, MD, Ph.D
Surgical Oncologist
Vice President of the A.C.Camargo Cancer Center

Innovation and technology, patient to patient. This is the theme of the third edition of Next Frontiers to Cure Cancer, a translation of our beliefs: to provide integrative medicine based on scientific evidence and the world’s latest clinical protocols. This is the role of a Cancer Center – to combine science, knowledge and humanized treatment.

VENUE

WTC Events Center

The WTC Events Center and the Sheraton São Paulo WTC Hotel form together the most complete venue for events in Latin America. An integrating part of the WTC São Paulo, the WTC Events Center is located on the Berrini region, 6 km from the Congonhas Airport and 36 km from the Guarulhos International Airport. An useable area of 12,000 square meters divided into 60 flexible spaces which can host from large corporate and cultural events to small business meetings.

PROGRAM

May 09 | Wednesday | 2018

SKIN TUMORS

Location: WTC Events Center Av. das Nações Unidas, 12551 - Av. das Nações Unidas - Brooklin Novo, São Paulo - SP, 04578-903
Capacity: 200 seats

SESSION I 13:45 às 15:00 SESSION I - SKIN CARCINOMAS
Coordinator: MARCO ANTONIO DE OLIVEIRA - A.C.CAMARGO CANCER CENTER
Panelists: GISELLE DE BARROS - CENTRO PAULISTA DE ONCOLOGIA, MAURO ENOKIHARA - ESCOLA PAULISTA DE MEDICINA
13:45 - 14:05 Chemoprophylaxis and treatment of field cancerization
Speaker - IVANA LAMEIRAS GIBBONS - A.C.CAMARGO CANCER CENTER
14:05 - 14:15 Treatment of early lesions: superficial BCC and SCC in situ
Speaker - ELIMAR GOMES - BP
14:15 - 14:30 Day Light PDT
Speaker - FRANCISCO PASCHOAL - FMABC
14:30 - 14:45 Systemic treatment of locally advanced or metastatic BCC and SCC
Speaker - MILTON JOSÉ DE BARROS E SILVA - A.C.CAMARGO CANCER CENTER
14:45 - 15:00 Debate
SESSION II 15:00 às 16:10 SESSION II - FREQUENTLY ASKED QUESTIONS I
Coordinator: EDUARD RENE BRECHTBUHL - A.C.CAMARGO CANCER CENTER
15:00 - 15:15 Photoprotection: When? How?
Speaker - TATIANA CRISTINA MORAES PINTO - A.C.CAMARGO CANCER CENTER
15:15 - 15:30 I had melanoma and now I want to get pregnant. Can I? When?
Speaker - FERNANDA BERTI ROCHA MENDES - A.C.CAMARGO CANCER CENTER
15:30 - 15:45 A lesion highly suspicious of melanoma – can it be removed with margins?
Speaker - IVAN FILHO - A.C.CAMARGO CANCER CENTER
15:45 - 16:00 After removing a skin tumor, how do I take care of the scar?
Speaker - FERNANDO PARRO - A.C.CAMARGO CANCER CENTER
16:00 - 16:10 Q&A - Discussion
16:10 às 16:30 COFFEE BREAK
16:30 às 18:00 SESSION III - PATHOLOGY
Coordinator: RUTE LELLIS - A.C.CAMARGO CANCER CENTER
Panelists: MILVIA ENOKIHARA (EPM) - ESCOLA PAULISTA DE MEDICINA, MIRIAN SOTO - USP, RUTE LELLIS - A.C.CAMARGO CANCER CENTER
16:30 - 16:45 What has the AJCC 8th edition changed in everyday practice?
Speaker - NÍLCEO MICHALANY
16:45 - 17:00 Benign vs. Atypical Spitzoid Lesions vs. Spitzoid Melanoma: How to define them?
Speaker - GILLES LANDMAN - ESCOLA PAULISTA DE MEDICINA
17:00 - 17:15 Anatomic pathology evaluation of SLN
Speaker - CLOVIS PINTO - A.C.CAMARGO CANCER CENTER
17:15 - 17:30 Incorporation of molecular biology into everyday practice
Speaker - MARIANA PETACCIA - A.C.CAMARGO CANCER CENTER
17:30 - 18:00 Q&A - Discussion
ADJOURN 18:00 ADJOURN

May 10 | Thursday | 2018

HEAD AND NECK

08:00 às 08:30 WELCOME COFFEE
08:30 às 10:00 SESSION I – EPIDEMIOLOGY OF HEAD AND NECK CANCER
Moderators: JOSÉ MAGRIN - A.C.CAMARGO CANCER CENTER, RAQUEL A MOYSES - FMUSP
08:30 - 09:00 Recent Changes on the Epidemiology of Head and Neck Cancer in South America
Speaker - MARIA PAULA CURADO - A.C.CAMARGO CANCER CENTER
09:00 - 09:30 HPV infection in men: contributions of the HIM study
Speaker - LUIZA L VILLA - FMUSP, ICESP
09:30 - 10:00 Diabetes mellitus, metfarmin and head and neck cancer
Speaker - VICTOR WUNSCH FILHO - FSPUSP
10:00 às 10:30 COFFEE BREAK
SESSION II 10:30 às 12:00 SESSION II – DIAGNOSIS AND STAGING OF HEAD AND NECK CANCER
Moderators: MAURO KASUO IKEDA - A.C.CAMARGO CANCER CENTER, CARLOS R SANTOS - HC BARRETOS
10:30 - 11:00 Challanges for prevention and screening of head and neck cancer in Brazil
Speaker - THIAGO CELESTINO CHULAM - A.C.CAMARGO CANCER CENTER
11:00 - 11:30 Imaging methods on diagnosis, staging and post treatment monitoring of head and neck cancer
Speaker - GISLAINE C L M PORTO - A.C.CAMARGO CANCER CENTER
11:30 - 12:00 AJCC/UICC 8th edition. The most significant modificatons
Speaker - HUGO FONTAN KOHLER - A.C.CAMARGO CANCER CENTER
LUNCH 12:00 às 14:00 LUNCH
14:00 às 15:30 SESSION III – HEAD AND NECK CANCER MOLECULAR CHARACTERIZATION AND IMPLICATIONS ON DIAGNOSIS AND TREATMENT
Moderators: EMMANUEL DIAS NETO - A.C.CAMARGO CANCER CENTER, LUDMILLA THOME DOMINGOS CHINEN - A.C.CAMARGO CANCER CENTER
14:00 - 14:30 Comprehensive genomic characterization of head and neck squaous cell carcinoma and the current implications for diagnosis and treatment
Speaker - NISHANT AGRAWAL - UNIVERSITY OF CHICAGO
14:30 - 15:00 Molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platfform
To Be Defined -
15:00 - 15:30 Circulating tumor cells, vesicles and DNA as emerging biomarkers in head and nec
Speaker - THIAGO BUENO DE OLIVEIRA - A.C.CAMARGO CANCER CENTER
15:30 às 16:00 COFFEE BREAK
SESSION IV 16:00 às 17:30 SESSION IV - MULTIDISCIPLINARY TREATMENT OF HEAD AND NECK CANCER
Moderators: JOÃO GONÇALVES FILHO - A.C.CAMARGO CANCER CENTER, ULISSES RIBALDO NICOLAU - A.C.CAMARGO CANCER CENTER
16:00 - 16:30 The role of head and neck surgeons in current multidisciplinary treatment of head and neck cancer
To Be Defined - to be defined
16:30 - 17:00 Evidence-based radiaton therapy in hea and neck oncology with a focus on tumor site and treatment modality
Speaker - ANTÔNIO CÁSSIO ASSIS PELLIZZON - A.C.CAMARGO CANCER CENTER
17:00 - 17:30 Optimizing systemic therapies indications in head and neck cancer patients.
Speaker - WILLIAM N. WILLIAM - BP
ADJOURN 17:30 ADJOURN
17:45 às 19:00
Keynote Speaker - GIORGIO TRINCHIERI - NATIONAL CANCER INSTITUTE

May 11 | Friday | 2018

HEAD AND NECK

08:00 às 08:30 WELCOME COFFEE
08:30 às 10:00 SESSION I – ORAL CAVITY CANCER
Moderators: IVAN M. AGRA - FACULDADE DE MEDICINA DA BAHIA/ UNIVERSIDADE FEDERAL DA BAHIA, MARCOS B CARVALHO – HOSPITAL HELIOPOLIS
08:30 - 08:50 Current treatment of advanced stage oral cancer.
Speaker - LUIZ PAULO KOWALSKI - A.C.CAMARGO CANCER CENTER
08:50 - 09:10 Surgical Margins evaluation in oral cancer
Speaker - CLOVIS ANTONIO LOPES PINTO - A.C.CAMARGO CANCER CENTER
09:10 - 09:30 Long term results of selective neck dissection for cN+ neck:
Speaker - JOSÉ G VARTANIAN - A.C.CAMARGO CANCER CENTER
09:30 - 10:00 Conference: How we have implemented active surveillance for thyroid cancer at MSK and in the US
Speaker -
10:00 às 10:30 COFFEE BREAK
SESSION II 10:30 às 12:00 SESSION II – OROPHARYNX CANCER
Moderators: OLAVO FEHER - ICESP, SERGIO S ARAP - FMUSP
10:30 - 10:50 HPV and oropharynx cancer in South America
Speaker - GILBERTO DE CASTRO JR. - FMUSP, ICESP
10:50 - 11:10 Guidelines fot the treatment of HPV+ and HPV- oropharynx cancer in South America
Speaker - ALINE LAUDA - LACOG
11:10 - 11:30 TORS – Brazilian experience
Speaker - RENAN B. LIRA - A.C.CAMARGO CANCER CENTER
11:30 - 12:00 CONFERÊNCIA HPV and host genomic interactions in head and neck squamous cell car
Speaker - NISHANT AGRAWAL - UNIVERSITY OF CHICAGO
LUNCH 12:00 às 14:00 LUNCH
14:00 às 15:30 SESSION III – LARYNX CÂNCER
Moderators: ANDRÉ DE CARVALHO - A.C.CAMARGO CANCER CENTER, AGRICIO CRESPO - UNICAMP
14:00 - 14:20 Indications, advantages and limitations of radiotherapy in early stage larynx ca
Speaker - GUSTAVO N MARTA - ICESP
14:20 - 14:40 Organ preservagion in Stage II larynx cancer
Speaker - GENIVAL B. CARVALHO - A.C.CAMARGO CANCER CENTER
14:40 - 15:00 Salvage laryngectomy – indications and technical tips
Speaker - FERNANDO L DIAS - INCA
15:00 - 15:30 Conference: “Management of advanced stage larynx carcinoma”
Speaker - NISHANT AGRAWAL - UNIVERSITY OF CHICAGO
15:30 às 16:00 COFFEE BREAK
SESSION IV 16:00 às 17:30
Moderators: CLAUDIO R CERNEA - FMUSP, SÉRGIO HIDEKI SUZUKI - A.C.CAMARGO CANCER CENTER
16:00 - 16:20 Classification and long term results of temporal boné ressections
Speaker - JOSÉ R TESTA - A.C.CAMARGO CANCER CENTER E UNIFESP
16:20 - 16:40 Classification and long term results of endonsal resection of nasal cavity and paranasal malignant tumors
Speaker - RONALDO N. TOLEDO - A.C.CAMARGO CANCER CENTER
16:40 - 17:00 Videoassited nasopharyngectomy
Speaker - RONALDO N. TOLEDO - A.C.CAMARGO CANCER CENTER
17:00 - 17:30 Orbital preservation approaches – long term results
Speaker - RENATO CAPUZZO - HOSPITAL DE AMOR
ADJOURN 17:30 ADJOURN

May 12 | Saturday | 2018

AACR / LACOG

08:00 às 08:30 WELCOME COFFEE
SESSION I 08:30 às 09:30 DNA DAMAGE AND REPAIR SECTION
08:30 - 09:00 Development of PARP inhibitors in breast cancer: results of OlympiAD and EMBRACA trials
Speaker - GUSTAVO WERUTSKY - LACOG E HOSPITAL SAO LUCAS
09:00 - 09:30 BRCAness and Homologous Recombination Deficiency: rational for precision therapeutics
Speaker - JORGE REIS FILHO
09:30 às 10:30
09:30 - 10:00 Evaluating Current Strategies Using Checkpoint Inhibitors in Advanced/ Metastatic Lung Cancer
Speaker - VLADMIR CLAUDIO CORDEIRO DE LIMA - A.C.CAMARGO CANCER CENTER
10:00 - 10:30 Benefits and limitations of using PD-L1 as a biomarker to guide treatment selection with immunotherapy
Speaker - DAVID E. GERBER - HAROLD C. SIMMONS COMPREHENSIVE CANCER CENTER
10:30 às 11:00 COFFEE BREAK
SESSION III 11:00 às 12:00
11:00 - 11:30 BRAF and MEK inhibitors in Lung Cancer: current status and perspectives BRAF mutated NSCLC
Speaker - CARLOS H BARRIOS - LACOG E INSTITUTO DO CANCER MAE DE DEUS
11:30 - 12:00 Development of BRAF and MEK combination in melanoma and mechanisms of resistance
Speaker - MARÍA ROMINA GIROTTI - INSTITUTO DE BIOLOGIA Y MEDICINA EXPERIMENTAL (IBYME)
12:00 - 12:00 ENCERRAMENTO

INTERNATIONAL SPEAKERS

Banu Arun
Oncogenetics
Bandeira
Bruce Wenig
Pathology - Head and Neck Program
Bandeira
Cesar Nunez
Pediatric Tumors Program
Bandeira
Dan Dominissini
Basic and Translational Science
Bandeira
Daniel de Carvalho
Basic and Translational Science
Bandeira
Diana Bell
Pathology - Head and Neck Program
Bandeira
Dr Kyu Rhee
Innovations and Technology
Bandeira
Gary Rodin
Communication and Stress Management
Bandeira
Giorgio Trinchieri
Basic and Translational Research Program
Bandeira
Glauco R. Souza
Basic and Translational Research Program
Bandeira
Mauro Avanzi
Hematology-Oncology
Bandeira
Nishant Agrawal
Head and Neck Program
Bandeira
Raul Ribeiro
Pediatric Tumors Program
Bandeira
Susan Müller
Head and Neck Program
Bandeira
Vernon Sondak
Head and Neck Program
Bandeira
William Nassib William
Head and Neck Program
Bandeira

NATIONAL SPEAKERS



Adriana Goes
Patients' Forum




Aline Donati
Skin Tumors




Ana Paula Lepique
Immunotherapy




André de Carvalho
Head and Neck Program




André S. Molina
Skin Tumors




Andrew Maltez Thomas
Basic to Translational Science




Armando Ribeiro
Communication and Stress Management




Carlos Barcaui
Skin Tumors




Carlos Chiattone
Hematology-Oncology




Celso Arrais
Onco Hemato




Christina Haas Tarabay
Patients' Forum




Diana Nunes Noronha
Immunotherapy




Douglas Guedes
Brain Tumors




Eddie Murta
Immunotherapy




Eduardo Rego
Hematology-Oncology




Edvan Crusoé
Hematology-Oncology




Eliane Kihara
Innovation and Technology Program




Fabiana Makdissi
Patients' Forum




Fabio Gandour
Basic and Translational Research Program




Felipe Gaia
Brain Tumors




Flávio Cavarsan
Skin Tumors




Glaucia Hajj
Basic and Translational Science




Graziela P. P. Baladão
Pediatric tumors




Gustavo Nader Marta
Head and neck




Jacson Luiz Fressatto
Innovation and Technology Program




José Vassallo
Hematology-Oncology




Leonardo Avila
Skin Tumors




Louise Lovatto
Skin Tumors




Luciano J. Costa
Hematology-Oncology




Ludmilla Chinen
Basic and Translational Science and Head and Neck




Luis Fernando Pracchia
Hematology-Oncology




Luisa Lina Villa
Cabeça e pescoço




Maria Del Pilar
Oncogenetics




Maria Paula Curado
Basic and Translational Science and Head and Neck




Martin Bonamino
Immunotherapy




Mauro Enokihara
Skin Tumors




Niels Olsen Saraiva Câmara
Basic and Translational Science




Nirvana Formiga
Oncogenetics




Priscila Ishioka
Skin Tumors




Prof. Angelo Maiolino
Hematology-Oncology




Sergio Hirata
Skin Tumors




Simone Lehwess Mozzilli
Pediatric Tumors




Thais Miola
Patients' Forum




Tiago Matos
Patients' Forum



SCIENTIFIC PAPERS

O Next Frontiers to Cure Cancer will accept scientific papers for its poster sessions.

Only original papers will be accepted, i.e. not previously published in any scientific journals. Abstracts must be submitted in English or Portuguese and the deadline for submission of the abstracts is April 16, 2018, by 11:59 pm..

Papers will be classified into the following categories: clinical trial, basic translational, quality of life, epidemiology and others.

If your abstract is selected for poster and/or oral presentation, the main author and a second co-author will enjoy a complimentary 3-day conference pass.

COMMITTES

EXECUTIVE


Dr. Ademar Lopes
Edna Rodrigues Bedani
Dr. Felipe José Fernández Coimbra
Dr. José Humberto Tavares Guerreiro Fregnani
Dr. Luiz Juliano Neto
Dr. Victor Piana de Andrade
Drª. Vilma Regina Martins

SCIENTIFIC


Drª. Ana Carolina Sigolo Levy
Dr. Antonio Geraldo Nascimento
Drª. Cecília Maria Lima da Costa
Dr. Clovis Antonio Lopes Pinto
Drª Dirce Maria Carraro
Drª. Elisabete Carrara
Dr. Emmanuel Dias-Neto
Dr. Fabio de Abreu Alves
Dr. Felipe D’Almeida Costa
Dr. Garles Miller Matias Vieira
Drª. Glaucia Hajj
Dr. Glauco Baiocchi Neto
Dr. Helano Carioca Freitas
Dr. Israel Tojal da Silva
Dr. Jayr Schmidt Filho
Dr. Jefferson Luiz Gross
Dr. Kenneth John Gollob
Dr. João Pedreira Duprat Neto
Dr. José Augusto Rinck Junior
Dr. Luiz Paulo Kowalski
Maria Aparecida Abreu Da Silva
Drª. Maria Nirvana da Cruz Formiga
Drª. Maria Teresa Duarte Pereira da Cruz
Dr. Milton José de Barros e Silva
Dr. Sérgio Hideki Suzuki
Dr. Thiago Bueno de Oliveira
Dr. Tiago Góss dos Santos
Drª. Vilma Regina Martins
Dr. Vladmir Claudio Cordeiro de Lima

News

  • Studies investigating how liquid biopsy can potentially enable less invasive diagnosis and monitoring of Wilms' tumor, a renal cancer that predominantly affects children aged 2 to 5 years, are among the highlights of the Pediatric Oncology panel of the 3rd Next Frontiers to Cure Cancer, an international congress promoted by the ACCamargo Cancer Center that will take place on May 10-12, 2018, in São Paulo.

    The aim of the investigators is to use urine and blood samples to identify the most prevalent somatic mutations in these tumors, which represent a less invasive method for early Wilms' tumor screening. Currently, diagnosis is based on traditional biopsy of patients who already have a palpable mass, leading to more aggressive therapies and more intense side effects.

    Scientist and coordinator of ACCamargo's Laboratory of Genomics and Molecular Biology, Dirce Maria Carraro led the study published in 2014 in Nature Communications, which identified new high frequent mutations in Wilms' tumor, including those in the DROSHA gene, expanding the panel of changes associated with this type of cancer. Investigators from other institutions such as the Hospital for Sick Children and Cancer Control Alberta, both from Canada, as well as the Hospital Sírio-Libanês and Brazil's National Cancer Institute (INCA) participated in the study.

    The expansion of this panel has paved the way for further research on subjects such as liquid biopsy. According to Dirce Carraro, this analysis could be a new frontier for curing Wilms tumor, a disease affecting one in every 10,000 children. "If we can diagnose Wilms’ tumor by finding tumor DNA in patients' urine, we can start treating them before the first symptoms develop," says Dirce Carraro.

    LEUKEMIA - The most prevalent cancer in children will also be a focal point of the Pediatric Oncology panel. We’d like to highlight the presentations that will be delivered by researchers César Nunez, an expert in lymphoid leukemia from the MDAnderson Cancer Center of the University of Texas, and Raul Ribeiro, a Brazilian who’s been in the US for over 30 years investigating advances in myeloid leukemia at St. Jude Children's Research Hospital. "There are many developments around leukemias and we would like to exchange information with professionals from centers with different realities", says Cecília Lima da Costa, director of the Pediatric Oncology department at the ACCamargo Cancer Center and coordinator of the panel's scientific program.

    The Pediatric Oncology panel is targeted at oncologists, hematologists, multidisciplinary professionals, residents and medical students involved with Pediatric Oncology as an opportunity to discuss state-of-the-art approaches and technological innovations in diagnosis and treatment, as well the most recent scientific publications in this field. The 12 lectures of the panel on pediatric tumors will take place on May 11 and 12. This program stands out for stressing the importance of differentiating children's protocols from those of adults’, valuing the experience of institutions and professionals specializing in cancer. Multidisciplinary classes on nursing, nutrition and humanization will close this panel program.

    Click here and sign up

  • Gene panels for hereditary cancer, one of largest innovations in Oncogenetics over the last couple of years, will be the subject addressed by Jeffrey N. Weitzel, MD, director of the Clinical Cancer Genetics Program at City of Hope, CA. Dr. Weitzel is the guest that will address this issue in the Oncogenetics panel on the last day of Next Frontiers conference.

    These gene panels allow for sequencing several genes using a single sample (NGS, next generation sequencing), rapidly and concurrently. As a leading researcher in Oncogenetics, Dr. Weitzel will address the challenges and interpretation of multigene panels.

    During the entire morning of Saturday, Monday 12, the Oncogenetics session will host nine speakers to talk about Oncogenetics, Genetic Counseling, Screening, and Hereditary Cancer Predisposition Syndromes. At the end we’ll open for questions and discussion with the audience.

    Besides Dr. Jeffrey Weitzel presentation, the highlights are

    Familial breast cancer with wild-type BRCA: genetic changes related to moderate cancer risk and patients without known mutations. Dr. Banu Arun, MD Anderson Cancer Center. Dr. Arun is a leading researcher in familial breast cancer.

    (Brazilian Network of Hereditary Cancer) Rede Brasileira de Câncer Hereditário: Geneticist Patrícia Prolla, MD, PhD, coordinator of the network and professor at the Department of Genetics at UFRGS. Dr. Prolla will give us a lecture on Application of Oncogenetics and the challenge to ensure access to tests via private health insurance companies. Li-Fraumeni syndrome: It is estimated that this syndrome affects one out of every five thousand people worldwide, but in Brazil’s south and southeast regions there is one new case for every 330 people. A.C.Camargo Cancer Center has the largest number of patients with Li-Fraumeni syndrome globally. Today more than 150 families with this syndrome are followed at ACCamargo Cancer Center. Dr. Maria Nirvana Formiga will talk about Li Fraumeni clinical features and Dr. Daniele Paixão will talk about screening it.

    Ovarian epithelial tumors: Dr. Alexandre André, A.C.Camargo Oncogenetics, will talk about tumor changes vs. germline mutations and the impact on screening and personalized therapy in ovarian carcinoma.

    Familial colorectal cancer: Dr. Benedito Mauro Rossi, surgical oncologist at Hospital Sírio Libanês, will give a lecture on who needs genetic counseling for colorectal cancer.

    Research in hereditary cancer: Dr. Dirce Carraro, researcher at CIPE and director of the Genomics laboratory at A.C .Camargo Cancer Center, will talk about where we stand and the future of hereditary tumor research.

HOTELS

Hotel Estanplaza Berrini
Av. Eng. Luis Carlos Berrini, 853 – CEP: 04571-010 – Brooklin Novo.
www.estanplaza.com.br
Rate
Single: BRL 330.00/Double: BRL 377.00 – subject to change
Rates include breakfast and WI-FI
No service taxes added
Add 5% city tax + BRL 4.30 tourism taxGuest parking
BRL 20.00 per dayGuest reservations: (11) 3059-3277 or send us an email reservas@estanplaza.com.br

Make sure you mention you are participating of the Next Frontier to Cure Cancer 2018

The Time Othon Suítes – São Paulo
Rua Hans Oersted, 115 – Brooklin Novo – SP
www.othon.com.br
Room Type: SUPERIOR
Rates: BRL230.00 + 5% SINGLE // BRL260.00 + 5% DOUBLEConditions:
Rates in BRL, no commissions
Complimentary breakfast served at the restaurant 06:30 am – 10:30 am
Free WI-FI in rooms
Complimentary parking for 01 car (from check in to check out)
Check in at 12:00 pm and check out at 12:00 pm)reservas@thetimeflat.com.br

Hotel TRYP Berrini
Rua Quintana, 934 – Brooklin Novo. Tel.: 11 5502.3800 – Fax: 11 5502.3801
Tryphotels.com

ROOMS AND RATES
Check-in Check-out Room Type SGL rate (1 person) Double rate (2 people)
10/05/2018 12/05/2018 Tryp Room BLR 315,00 BLR 345,00
10/05/2018 12/05/2018 PREMIUM
Room
BLR 365,00 BLR 395,00

Add 5% city tax and tourism tax of BRL4.30 + 5% sales tax (non mandatory)
Complimentary breakfast served at restaurante Lucca.
Parking excluded, BLR20.00 per day + 5% sales tax
Group reservations: penalties applicable for no show
Check in at 2:00 pm and check out at 12:00 pm
Early check in subject to availability. For reservations with check in before 11:00 am, pre-registration is required one day before check in.
Late check out subject to availability. A half day rate will be charged for check out until 4:00 pm and full rate for check out after 4:00 pm.
All prices are NET.

RESTAURANTS


Must show event badge

From 5/10 to 5/12 at the D&D shopping mal store


Buy any entrée and get a free dessert (1 milk pudding or 1 mousse).
Must show event badge

From 5/10 to 5/12 at the D&D shopping mal store

DivinaA ComédiaA
10% off all menu items and a complimentary cup of coffee.
Must show event badge

From 5/10 to 5/12 at the D&D shopping mal store


10% off all menu items and a complimentary Caffé Cannoli
Must show event badge

From 5/10 to 5/12 at the D&D shopping mal store

TRANSPORTATION

Enter promotion code #NEXTFRONTIERS to benefit from 30% off (up to BRL10.00) in six trips with CABIFY to and from NEXT FRONTIERS!

Instructions:

1) Download the CABIFY app from Google Play (Android) or the AppleStore (iOS)

2) Register a new user and add a credit card

3) Click on the top left corner to view your profile

4) Select Promotions and enter code #NEXTFRONTIERS

5) alid for all trips within CABIFY SP covered areas
***Type NEXT FRONTIERS as your ‘where from’ or ‘where to’ location and ask for a CABIFY LITE or CAB***

6) Valid for all trips ending by 5/12/2018 11:00 pm

7) The code can only be used from 5/10/2018 to 5/12/2018 11:00 pm.

8) Not valid for corporate accounts

Our Sponsors

Patrocinador Diamante





Patrocinador Prata





Our Supporters

ORGANIZATIONS THAT SUPPORT US


Congress Attendee

0800 7713388